REPORT ID 2606

Global Gout Therapeutics Market Size, Status and Forecast 2022

Publish Date
11-Dec-17
Pages
113
Format
Electronic (PDF)

This report studies the global Gout Therapeutics market, analyzes and researches the Gout Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
    AstraZeneca
    Takeda Pharmaceuticals
    Horizon Pharma
    Merck
    Novartis
    Sanofi
    GlaxoSmithKline
    Eli Lilly
    Boehringer Ingelheim
    Novo Nordisk
    LG Life Sciences
    Antares Pharma
    Astellas Pharma
    Eisai
    JW Pharmaceutical
    Teijin Pharma
    Vertex Pharmaceuticals
    Sandoz
    Regeneron Pharmaceuticals
    CymaBay Therapeutics
    Ablynx

Market segment by Regions/Countries, this report covers
    United States
    EU
    Japan
    China
    India
    Southeast Asia

Market segment by Type, the product can be split into
    NSAIDs
    Corticosteroids
    Colchicine
    Urate-Lowering Agents
    Other

Market segment by Application, Gout Therapeutics can be split into
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

If you have any special requirements, please let us know and we will offer you the report as you want.


 
			   
Table of Contents

Global Gout Therapeutics Market Size, Status and Forecast 2022
1 Industry Overview of Gout Therapeutics
    1.1  Gout Therapeutics Market Overview
        1.1.1 Gout Therapeutics Product Scope
        1.1.2 Market Status and Outlook
    1.2 Global Gout Therapeutics Market Size and Analysis by Regions
        1.2.1 United States
        1.2.2 EU
        1.2.3 Japan
        1.2.4 China
        1.2.5 India
        1.2.6 Southeast Asia
    1.3 Gout Therapeutics Market by Type
        1.3.1 NSAIDs
        1.3.2 Corticosteroids
        1.3.3 Colchicine
        1.3.4 Urate-Lowering Agents
        1.3.5 Other
    1.4 Gout Therapeutics Market by End Users/Application
        1.4.1 Hospital Pharmacies
        1.4.2 Retail Pharmacies
        1.4.3 Online Pharmacies

2 Global Gout Therapeutics Competition Analysis by Players
    2.1 Gout Therapeutics Market Size (Value) by Players (2016 and 2017)
    2.2 Competitive Status and Trend
        2.2.1 Market Concentration Rate
        2.2.2 Product/Service Differences
        2.2.3 New Entrants
        2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
    3.1 AstraZeneca
        3.1.1 Company Profile
        3.1.2 Main Business/Business Overview
        3.1.3 Products, Services and Solutions
        3.1.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.1.5 Recent Developments
    3.2 Takeda Pharmaceuticals
        3.2.1 Company Profile
        3.2.2 Main Business/Business Overview
        3.2.3 Products, Services and Solutions
        3.2.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.2.5 Recent Developments
    3.3 Horizon Pharma
        3.3.1 Company Profile
        3.3.2 Main Business/Business Overview
        3.3.3 Products, Services and Solutions
        3.3.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.3.5 Recent Developments
    3.4 Merck
        3.4.1 Company Profile
        3.4.2 Main Business/Business Overview
        3.4.3 Products, Services and Solutions
        3.4.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.4.5 Recent Developments
    3.5 Novartis
        3.5.1 Company Profile
        3.5.2 Main Business/Business Overview
        3.5.3 Products, Services and Solutions
        3.5.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.5.5 Recent Developments
    3.6 Sanofi
        3.6.1 Company Profile
        3.6.2 Main Business/Business Overview
        3.6.3 Products, Services and Solutions
        3.6.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.6.5 Recent Developments
    3.7 GlaxoSmithKline
        3.7.1 Company Profile
        3.7.2 Main Business/Business Overview
        3.7.3 Products, Services and Solutions
        3.7.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.7.5 Recent Developments
    3.8 Eli Lilly
        3.8.1 Company Profile
        3.8.2 Main Business/Business Overview
        3.8.3 Products, Services and Solutions
        3.8.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.8.5 Recent Developments
    3.9 Boehringer Ingelheim
        3.9.1 Company Profile
        3.9.2 Main Business/Business Overview
        3.9.3 Products, Services and Solutions
        3.9.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.9.5 Recent Developments
    3.10 Novo Nordisk
        3.10.1 Company Profile
        3.10.2 Main Business/Business Overview
        3.10.3 Products, Services and Solutions
        3.10.4 Gout Therapeutics Revenue (Value) (2012-2017)
        3.10.5 Recent Developments
    3.11 LG Life Sciences
    3.12 Antares Pharma
    3.13 Astellas Pharma
    3.14 Eisai
    3.15 JW Pharmaceutical
    3.16 Teijin Pharma
    3.17 Vertex Pharmaceuticals
    3.18 Sandoz
    3.19 Regeneron Pharmaceuticals
    3.20 CymaBay Therapeutics
    3.21 Ablynx

4 Global Gout Therapeutics Market Size by Type and Application (2012-2017)
    4.1 Global Gout Therapeutics Market Size by Type (2012-2017)
    4.2 Global Gout Therapeutics Market Size by Application (2012-2017)
    4.3 Potential Application of Gout Therapeutics in Future
    4.4 Top Consumer/End Users of Gout Therapeutics

5 United States Gout Therapeutics Development Status and Outlook
    5.1 United States Gout Therapeutics Market Size (2012-2017)
    5.2 United States Gout Therapeutics Market Size and Market Share by Players (2016 and 2017)

6 EU Gout Therapeutics Development Status and Outlook
    6.1 EU Gout Therapeutics Market Size (2012-2017)
    6.2 EU Gout Therapeutics Market Size and Market Share by Players (2016 and 2017)

7 Japan Gout Therapeutics Development Status and Outlook
    7.1 Japan Gout Therapeutics Market Size (2012-2017)
    7.2 Japan Gout Therapeutics Market Size and Market Share by Players (2016 and 2017)

8 China Gout Therapeutics Development Status and Outlook
    8.1 China Gout Therapeutics Market Size (2012-2017)
    8.2 China Gout Therapeutics Market Size and Market Share by Players (2016 and 2017)

9 India Gout Therapeutics Development Status and Outlook
    9.1 India Gout Therapeutics Market Size (2012-2017)
    9.2 India Gout Therapeutics Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Gout Therapeutics Development Status and Outlook
    10.1 Southeast Asia Gout Therapeutics Market Size (2012-2017)
    10.2 Southeast Asia Gout Therapeutics Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
    11.1 Global Gout Therapeutics Market Size (Value) by Regions (2017-2022)
        11.1.1 United States Gout Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.2 EU Gout Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.3 Japan Gout Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.4 China Gout Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.5 India Gout Therapeutics Revenue and Growth Rate (2017-2022)
        11.1.6 Southeast Asia Gout Therapeutics Revenue and Growth Rate (2017-2022)
    11.2 Global Gout Therapeutics Market Size (Value) by Type (2017-2022)
    11.3 Global Gout Therapeutics Market Size by Application (2017-2022)

12 Gout Therapeutics Market Dynamics
    12.1 Gout Therapeutics Market Opportunities
    12.2 Gout Therapeutics Challenge and Risk
        12.2.1 Competition from Opponents
        12.2.2 Downside Risks of Economy
    12.3 Gout Therapeutics Market Constraints and Threat
        12.3.1 Threat from Substitute
        12.3.2 Government Policy
        12.3.3 Technology Risks
    12.4 Gout Therapeutics Market Driving Force
        12.4.1 Growing Demand from Emerging Markets
        12.4.2 Potential Application

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs Trend/Customer Preference
    13.3 External Environmental Change
        13.3.1 Economic Fluctuations
        13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
    Methodology
    Analyst Introduction
    Data Source